Association of regimens of hormone replacement therapy to prognostic factors among women diagnosed with breast cancer aged 50-64 years.
Daling JR, Malone KE, Doody DR, Voigt LF, Bernstein L, Marchbanks PA, Coates RJ, Norman SA, Weiss LK, Ursin G, Burkman RT, Deapen D, Folger SG, McDonald JA, Simon MS, Strom BL, Spirtas R.
Daling JR, et al. Among authors: bernstein l.
Cancer Epidemiol Biomarkers Prev. 2003 Nov;12(11 Pt 1):1175-81.
Cancer Epidemiol Biomarkers Prev. 2003.
PMID: 14652277